Industry Research Reports

Home > Reports > Medical Devices & Consumables > Vial and Prefilled Syringe - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Vial and Prefilled Syringe - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Medical Devices & Consumables

Published: 2024-01-16

Pages: 133 Pages

Report ld: 2229866

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

The global market for Vial and Prefilled Syringe was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

North American market for Vial and Prefilled Syringe was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Vial and Prefilled Syringe was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Vial and Prefilled Syringe was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Vial and Prefilled Syringe include BD (US), Gerresheimer (DE), Nipro Corporation (JP), Schott forma vitrum (DE), Ompi (IT), Baxter BioPharma Solution (US), ROVI CM (ES), Terumo (JP) and Vetter (DE), etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Vial and Prefilled Syringe, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Vial and Prefilled Syringe by region & country, by Type, and by Application.

The Vial and Prefilled Syringe market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vial and Prefilled Syringe.

Market Segmentation

Report Metric
Details
Report Title
Vial and Prefilled Syringe - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Global Vial and Prefilled Syringe Companies Covered
BD (US), Gerresheimer (DE), Nipro Corporation (JP), Schott forma vitrum (DE), Ompi (IT), Baxter BioPharma Solution (US), ROVI CM (ES), Terumo (JP), Vetter (DE), Unilife Corporation (US), Taisei Kako (JP), Roselabs Group (IN), ARTE CORPORATION (JP), Weigao Group Medical Polymer (CN), Zibo Minkang Pharmaceutical (CN), Shandong Pharmaceutical Glass (CN)
Global Vial and Prefilled Syringe Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Vial and Prefilled Syringe Market, Segment by Type
Glass Vial and Prefilled Syringe

Polymer Vial and Prefilled Syringe
Global Vial and Prefilled Syringe Market, Segment by Application
Antithrombotics

Vaccines

Autoimmune Diseases

Anti-inflammatory Drugs

Others
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Vial and Prefilled Syringe manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Vial and Prefilled Syringe in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Vial and Prefilled Syringe in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

 1 Market Overview
    1.1 Vial and Prefilled Syringe Product Introduction
    1.2 Global Vial and Prefilled Syringe Market Size Forecast
        1.2.1 Global Vial and Prefilled Syringe Sales Value (2019-2030)
        1.2.2 Global Vial and Prefilled Syringe Sales Volume (2019-2030)
        1.2.3 Global Vial and Prefilled Syringe Sales Price (2019-2030)
    1.3 Vial and Prefilled Syringe Market Trends & Drivers
        1.3.1 Vial and Prefilled Syringe Industry Trends
        1.3.2 Vial and Prefilled Syringe Market Drivers & Opportunity
        1.3.3 Vial and Prefilled Syringe Market Challenges
        1.3.4 Vial and Prefilled Syringe Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Vial and Prefilled Syringe Players Revenue Ranking (2023)
    2.2 Global Vial and Prefilled Syringe Revenue by Company (2019-2024)
    2.3 Global Vial and Prefilled Syringe Players Sales Volume Ranking (2023)
    2.4 Global Vial and Prefilled Syringe Sales Volume by Company Players (2019-2024)
    2.5 Global Vial and Prefilled Syringe Average Price by Company (2019-2024)
    2.6 Key Manufacturers Vial and Prefilled Syringe Manufacturing Base Distribution and Headquarters
    2.7 Key Manufacturers Vial and Prefilled Syringe Product Offered
    2.8 Key Manufacturers Time to Begin Mass Production of Vial and Prefilled Syringe
    2.9 Vial and Prefilled Syringe Market Competitive Analysis
        2.9.1 Vial and Prefilled Syringe Market Concentration Rate (2019-2024)
        2.9.2 Global 5 and 10 Largest Manufacturers by Vial and Prefilled Syringe Revenue in 2023
        2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vial and Prefilled Syringe as of 2023)
    2.10 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Glass Vial and Prefilled Syringe
        3.1.2 Polymer Vial and Prefilled Syringe
    3.2 Global Vial and Prefilled Syringe Sales Value by Type
        3.2.1 Global Vial and Prefilled Syringe Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Vial and Prefilled Syringe Sales Value, by Type (2019-2030)
        3.2.3 Global Vial and Prefilled Syringe Sales Value, by Type (%) (2019-2030)
    3.3 Global Vial and Prefilled Syringe Sales Volume by Type
        3.3.1 Global Vial and Prefilled Syringe Sales Volume by Type (2019 VS 2023 VS 2030)
        3.3.2 Global Vial and Prefilled Syringe Sales Volume, by Type (2019-2030)
        3.3.3 Global Vial and Prefilled Syringe Sales Volume, by Type (%) (2019-2030)
    3.4 Global Vial and Prefilled Syringe Average Price by Type (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Antithrombotics
        4.1.2 Vaccines
        4.1.3 Autoimmune Diseases
        4.1.4 Anti-inflammatory Drugs
        4.1.5 Others
    4.2 Global Vial and Prefilled Syringe Sales Value by Application
        4.2.1 Global Vial and Prefilled Syringe Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Vial and Prefilled Syringe Sales Value, by Application (2019-2030)
        4.2.3 Global Vial and Prefilled Syringe Sales Value, by Application (%) (2019-2030)
    4.3 Global Vial and Prefilled Syringe Sales Volume by Application
        4.3.1 Global Vial and Prefilled Syringe Sales Volume by Application (2019 VS 2023 VS 2030)
        4.3.2 Global Vial and Prefilled Syringe Sales Volume, by Application (2019-2030)
        4.3.3 Global Vial and Prefilled Syringe Sales Volume, by Application (%) (2019-2030)
    4.4 Global Vial and Prefilled Syringe Average Price by Application (2019-2030)

 5 Segmentation by Region
    5.1 Global Vial and Prefilled Syringe Sales Value by Region
        5.1.1 Global Vial and Prefilled Syringe Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Vial and Prefilled Syringe Sales Value by Region (2019-2024)
        5.1.3 Global Vial and Prefilled Syringe Sales Value by Region (2025-2030)
        5.1.4 Global Vial and Prefilled Syringe Sales Value by Region (%), (2019-2030)
    5.2 Global Vial and Prefilled Syringe Sales Volume by Region
        5.2.1 Global Vial and Prefilled Syringe Sales Volume by Region: 2019 VS 2023 VS 2030
        5.2.2 Global Vial and Prefilled Syringe Sales Volume by Region (2019-2024)
        5.2.3 Global Vial and Prefilled Syringe Sales Volume by Region (2025-2030)
        5.2.4 Global Vial and Prefilled Syringe Sales Volume by Region (%), (2019-2030)
    5.3 Global Vial and Prefilled Syringe Average Price by Region (2019-2030)
    5.4 North America
        5.4.1 North America Vial and Prefilled Syringe Sales Value, 2019-2030
        5.4.2 North America Vial and Prefilled Syringe Sales Value by Country (%), 2023 VS 2030
    5.5 Europe
        5.5.1 Europe Vial and Prefilled Syringe Sales Value, 2019-2030
        5.5.2 Europe Vial and Prefilled Syringe Sales Value by Country (%), 2023 VS 2030
    5.6 Asia Pacific
        5.6.1 Asia Pacific Vial and Prefilled Syringe Sales Value, 2019-2030
        5.6.2 Asia Pacific Vial and Prefilled Syringe Sales Value by Country (%), 2023 VS 2030
    5.7 South America
        5.7.1 South America Vial and Prefilled Syringe Sales Value, 2019-2030
        5.7.2 South America Vial and Prefilled Syringe Sales Value by Country (%), 2023 VS 2030
    5.8 Middle East & Africa
        5.8.1 Middle East & Africa Vial and Prefilled Syringe Sales Value, 2019-2030
        5.8.2 Middle East & Africa Vial and Prefilled Syringe Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Vial and Prefilled Syringe Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Vial and Prefilled Syringe Sales Value
        6.2.1 Key Countries/Regions Vial and Prefilled Syringe Sales Value, 2019-2030
        6.2.2 Key Countries/Regions Vial and Prefilled Syringe Sales Volume, 2019-2030
    6.3 United States
        6.3.1 United States Vial and Prefilled Syringe Sales Value, 2019-2030
        6.3.2 United States Vial and Prefilled Syringe Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Vial and Prefilled Syringe Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Vial and Prefilled Syringe Sales Value, 2019-2030
        6.4.2 Europe Vial and Prefilled Syringe Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Vial and Prefilled Syringe Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Vial and Prefilled Syringe Sales Value, 2019-2030
        6.5.2 China Vial and Prefilled Syringe Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Vial and Prefilled Syringe Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Vial and Prefilled Syringe Sales Value, 2019-2030
        6.6.2 Japan Vial and Prefilled Syringe Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Vial and Prefilled Syringe Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Vial and Prefilled Syringe Sales Value, 2019-2030
        6.7.2 South Korea Vial and Prefilled Syringe Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Vial and Prefilled Syringe Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Vial and Prefilled Syringe Sales Value, 2019-2030
        6.8.2 Southeast Asia Vial and Prefilled Syringe Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Vial and Prefilled Syringe Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Vial and Prefilled Syringe Sales Value, 2019-2030
        6.9.2 India Vial and Prefilled Syringe Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Vial and Prefilled Syringe Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 BD (US)
        7.1.1 BD (US) Company Information
        7.1.2 BD (US) Introduction and Business Overview
        7.1.3 BD (US) Vial and Prefilled Syringe Sales, Revenue and Gross Margin (2019-2024)
        7.1.4 BD (US) Vial and Prefilled Syringe Product Offerings
        7.1.5 BD (US) Recent Development
    7.2 Gerresheimer (DE)
        7.2.1 Gerresheimer (DE) Company Information
        7.2.2 Gerresheimer (DE) Introduction and Business Overview
        7.2.3 Gerresheimer (DE) Vial and Prefilled Syringe Sales, Revenue and Gross Margin (2019-2024)
        7.2.4 Gerresheimer (DE) Vial and Prefilled Syringe Product Offerings
        7.2.5 Gerresheimer (DE) Recent Development
    7.3 Nipro Corporation (JP)
        7.3.1 Nipro Corporation (JP) Company Information
        7.3.2 Nipro Corporation (JP) Introduction and Business Overview
        7.3.3 Nipro Corporation (JP) Vial and Prefilled Syringe Sales, Revenue and Gross Margin (2019-2024)
        7.3.4 Nipro Corporation (JP) Vial and Prefilled Syringe Product Offerings
        7.3.5 Nipro Corporation (JP) Recent Development
    7.4 Schott forma vitrum (DE)
        7.4.1 Schott forma vitrum (DE) Company Information
        7.4.2 Schott forma vitrum (DE) Introduction and Business Overview
        7.4.3 Schott forma vitrum (DE) Vial and Prefilled Syringe Sales, Revenue and Gross Margin (2019-2024)
        7.4.4 Schott forma vitrum (DE) Vial and Prefilled Syringe Product Offerings
        7.4.5 Schott forma vitrum (DE) Recent Development
    7.5 Ompi (IT)
        7.5.1 Ompi (IT) Company Information
        7.5.2 Ompi (IT) Introduction and Business Overview
        7.5.3 Ompi (IT) Vial and Prefilled Syringe Sales, Revenue and Gross Margin (2019-2024)
        7.5.4 Ompi (IT) Vial and Prefilled Syringe Product Offerings
        7.5.5 Ompi (IT) Recent Development
    7.6 Baxter BioPharma Solution (US)
        7.6.1 Baxter BioPharma Solution (US) Company Information
        7.6.2 Baxter BioPharma Solution (US) Introduction and Business Overview
        7.6.3 Baxter BioPharma Solution (US) Vial and Prefilled Syringe Sales, Revenue and Gross Margin (2019-2024)
        7.6.4 Baxter BioPharma Solution (US) Vial and Prefilled Syringe Product Offerings
        7.6.5 Baxter BioPharma Solution (US) Recent Development
    7.7 ROVI CM (ES)
        7.7.1 ROVI CM (ES) Company Information
        7.7.2 ROVI CM (ES) Introduction and Business Overview
        7.7.3 ROVI CM (ES) Vial and Prefilled Syringe Sales, Revenue and Gross Margin (2019-2024)
        7.7.4 ROVI CM (ES) Vial and Prefilled Syringe Product Offerings
        7.7.5 ROVI CM (ES) Recent Development
    7.8 Terumo (JP)
        7.8.1 Terumo (JP) Company Information
        7.8.2 Terumo (JP) Introduction and Business Overview
        7.8.3 Terumo (JP) Vial and Prefilled Syringe Sales, Revenue and Gross Margin (2019-2024)
        7.8.4 Terumo (JP) Vial and Prefilled Syringe Product Offerings
        7.8.5 Terumo (JP) Recent Development
    7.9 Vetter (DE)
        7.9.1 Vetter (DE) Company Information
        7.9.2 Vetter (DE) Introduction and Business Overview
        7.9.3 Vetter (DE) Vial and Prefilled Syringe Sales, Revenue and Gross Margin (2019-2024)
        7.9.4 Vetter (DE) Vial and Prefilled Syringe Product Offerings
        7.9.5 Vetter (DE) Recent Development
    7.10 Unilife Corporation (US)
        7.10.1 Unilife Corporation (US) Company Information
        7.10.2 Unilife Corporation (US) Introduction and Business Overview
        7.10.3 Unilife Corporation (US) Vial and Prefilled Syringe Sales, Revenue and Gross Margin (2019-2024)
        7.10.4 Unilife Corporation (US) Vial and Prefilled Syringe Product Offerings
        7.10.5 Unilife Corporation (US) Recent Development
    7.11 Taisei Kako (JP)
        7.11.1 Taisei Kako (JP) Company Information
        7.11.2 Taisei Kako (JP) Introduction and Business Overview
        7.11.3 Taisei Kako (JP) Vial and Prefilled Syringe Sales, Revenue and Gross Margin (2019-2024)
        7.11.4 Taisei Kako (JP) Vial and Prefilled Syringe Product Offerings
        7.11.5 Taisei Kako (JP) Recent Development
    7.12 Roselabs Group (IN)
        7.12.1 Roselabs Group (IN) Company Information
        7.12.2 Roselabs Group (IN) Introduction and Business Overview
        7.12.3 Roselabs Group (IN) Vial and Prefilled Syringe Sales, Revenue and Gross Margin (2019-2024)
        7.12.4 Roselabs Group (IN) Vial and Prefilled Syringe Product Offerings
        7.12.5 Roselabs Group (IN) Recent Development
    7.13 ARTE CORPORATION (JP)
        7.13.1 ARTE CORPORATION (JP) Company Information
        7.13.2 ARTE CORPORATION (JP) Introduction and Business Overview
        7.13.3 ARTE CORPORATION (JP) Vial and Prefilled Syringe Sales, Revenue and Gross Margin (2019-2024)
        7.13.4 ARTE CORPORATION (JP) Vial and Prefilled Syringe Product Offerings
        7.13.5 ARTE CORPORATION (JP) Recent Development
    7.14 Weigao Group Medical Polymer (CN)
        7.14.1 Weigao Group Medical Polymer (CN) Company Information
        7.14.2 Weigao Group Medical Polymer (CN) Introduction and Business Overview
        7.14.3 Weigao Group Medical Polymer (CN) Vial and Prefilled Syringe Sales, Revenue and Gross Margin (2019-2024)
        7.14.4 Weigao Group Medical Polymer (CN) Vial and Prefilled Syringe Product Offerings
        7.14.5 Weigao Group Medical Polymer (CN) Recent Development
    7.15 Zibo Minkang Pharmaceutical (CN)
        7.15.1 Zibo Minkang Pharmaceutical (CN) Company Information
        7.15.2 Zibo Minkang Pharmaceutical (CN) Introduction and Business Overview
        7.15.3 Zibo Minkang Pharmaceutical (CN) Vial and Prefilled Syringe Sales, Revenue and Gross Margin (2019-2024)
        7.15.4 Zibo Minkang Pharmaceutical (CN) Vial and Prefilled Syringe Product Offerings
        7.15.5 Zibo Minkang Pharmaceutical (CN) Recent Development
    7.16 Shandong Pharmaceutical Glass (CN)
        7.16.1 Shandong Pharmaceutical Glass (CN) Company Information
        7.16.2 Shandong Pharmaceutical Glass (CN) Introduction and Business Overview
        7.16.3 Shandong Pharmaceutical Glass (CN) Vial and Prefilled Syringe Sales, Revenue and Gross Margin (2019-2024)
        7.16.4 Shandong Pharmaceutical Glass (CN) Vial and Prefilled Syringe Product Offerings
        7.16.5 Shandong Pharmaceutical Glass (CN) Recent Development

 8 Industry Chain Analysis
    8.1 Vial and Prefilled Syringe Industrial Chain
    8.2 Vial and Prefilled Syringe Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Vial and Prefilled Syringe Sales Model
        8.5.2 Sales Channel
        8.5.3 Vial and Prefilled Syringe Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Vial and Prefilled Syringe Market Trends
    Table 2. Vial and Prefilled Syringe Market Drivers & Opportunity
    Table 3. Vial and Prefilled Syringe Market Challenges
    Table 4. Vial and Prefilled Syringe Market Restraints
    Table 5. Global Vial and Prefilled Syringe Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Vial and Prefilled Syringe Revenue Market Share by Company (2019-2024)
    Table 7. Global Vial and Prefilled Syringe Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Vial and Prefilled Syringe Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Vial and Prefilled Syringe Price by Company (2019-2024) & (USD/Unit)
    Table 10. Key Manufacturers Vial and Prefilled Syringe Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Vial and Prefilled Syringe Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Vial and Prefilled Syringe
    Table 13. Global Vial and Prefilled Syringe Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vial and Prefilled Syringe as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Vial and Prefilled Syringe Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Vial and Prefilled Syringe Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Vial and Prefilled Syringe Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Vial and Prefilled Syringe Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Vial and Prefilled Syringe Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Vial and Prefilled Syringe Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Vial and Prefilled Syringe Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Vial and Prefilled Syringe Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Vial and Prefilled Syringe Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Vial and Prefilled Syringe Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Vial and Prefilled Syringe Price by Type (2019-2024) & (USD/Unit)
    Table 27. Global Vial and Prefilled Syringe Price by Type (2025-2030) & (USD/Unit)
    Table 28. Global Vial and Prefilled Syringe Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Vial and Prefilled Syringe Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Vial and Prefilled Syringe Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Vial and Prefilled Syringe Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Vial and Prefilled Syringe Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Vial and Prefilled Syringe Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Vial and Prefilled Syringe Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Vial and Prefilled Syringe Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Vial and Prefilled Syringe Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Vial and Prefilled Syringe Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Vial and Prefilled Syringe Price by Application (2019-2024) & (USD/Unit)
    Table 39. Global Vial and Prefilled Syringe Price by Application (2025-2030) & (USD/Unit)
    Table 40. Global Vial and Prefilled Syringe Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Vial and Prefilled Syringe Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Vial and Prefilled Syringe Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Vial and Prefilled Syringe Sales Value by Region (2019-2024) & (%)
    Table 44. Global Vial and Prefilled Syringe Sales Value by Region (2025-2030) & (%)
    Table 45. Global Vial and Prefilled Syringe Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Vial and Prefilled Syringe Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Vial and Prefilled Syringe Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Vial and Prefilled Syringe Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Vial and Prefilled Syringe Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Vial and Prefilled Syringe Average Price by Region (2019-2024) & (USD/Unit)
    Table 51. Global Vial and Prefilled Syringe Average Price by Region (2025-2030) & (USD/Unit)
    Table 52. Key Countries/Regions Vial and Prefilled Syringe Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Vial and Prefilled Syringe Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Vial and Prefilled Syringe Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Vial and Prefilled Syringe Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Vial and Prefilled Syringe Sales Volume, (2025-2030) & (K Units)
    Table 57. BD (US) Company Information
    Table 58. BD (US) Introduction and Business Overview
    Table 59. BD (US) Vial and Prefilled Syringe Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 60. BD (US) Vial and Prefilled Syringe Product Offerings
    Table 61. BD (US) Recent Development
    Table 62. Gerresheimer (DE) Company Information
    Table 63. Gerresheimer (DE) Introduction and Business Overview
    Table 64. Gerresheimer (DE) Vial and Prefilled Syringe Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 65. Gerresheimer (DE) Vial and Prefilled Syringe Product Offerings
    Table 66. Gerresheimer (DE) Recent Development
    Table 67. Nipro Corporation (JP) Company Information
    Table 68. Nipro Corporation (JP) Introduction and Business Overview
    Table 69. Nipro Corporation (JP) Vial and Prefilled Syringe Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 70. Nipro Corporation (JP) Vial and Prefilled Syringe Product Offerings
    Table 71. Nipro Corporation (JP) Recent Development
    Table 72. Schott forma vitrum (DE) Company Information
    Table 73. Schott forma vitrum (DE) Introduction and Business Overview
    Table 74. Schott forma vitrum (DE) Vial and Prefilled Syringe Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 75. Schott forma vitrum (DE) Vial and Prefilled Syringe Product Offerings
    Table 76. Schott forma vitrum (DE) Recent Development
    Table 77. Ompi (IT) Company Information
    Table 78. Ompi (IT) Introduction and Business Overview
    Table 79. Ompi (IT) Vial and Prefilled Syringe Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 80. Ompi (IT) Vial and Prefilled Syringe Product Offerings
    Table 81. Ompi (IT) Recent Development
    Table 82. Baxter BioPharma Solution (US) Company Information
    Table 83. Baxter BioPharma Solution (US) Introduction and Business Overview
    Table 84. Baxter BioPharma Solution (US) Vial and Prefilled Syringe Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 85. Baxter BioPharma Solution (US) Vial and Prefilled Syringe Product Offerings
    Table 86. Baxter BioPharma Solution (US) Recent Development
    Table 87. ROVI CM (ES) Company Information
    Table 88. ROVI CM (ES) Introduction and Business Overview
    Table 89. ROVI CM (ES) Vial and Prefilled Syringe Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 90. ROVI CM (ES) Vial and Prefilled Syringe Product Offerings
    Table 91. ROVI CM (ES) Recent Development
    Table 92. Terumo (JP) Company Information
    Table 93. Terumo (JP) Introduction and Business Overview
    Table 94. Terumo (JP) Vial and Prefilled Syringe Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 95. Terumo (JP) Vial and Prefilled Syringe Product Offerings
    Table 96. Terumo (JP) Recent Development
    Table 97. Vetter (DE) Company Information
    Table 98. Vetter (DE) Introduction and Business Overview
    Table 99. Vetter (DE) Vial and Prefilled Syringe Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 100. Vetter (DE) Vial and Prefilled Syringe Product Offerings
    Table 101. Vetter (DE) Recent Development
    Table 102. Unilife Corporation (US) Company Information
    Table 103. Unilife Corporation (US) Introduction and Business Overview
    Table 104. Unilife Corporation (US) Vial and Prefilled Syringe Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 105. Unilife Corporation (US) Vial and Prefilled Syringe Product Offerings
    Table 106. Unilife Corporation (US) Recent Development
    Table 107. Taisei Kako (JP) Company Information
    Table 108. Taisei Kako (JP) Introduction and Business Overview
    Table 109. Taisei Kako (JP) Vial and Prefilled Syringe Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 110. Taisei Kako (JP) Vial and Prefilled Syringe Product Offerings
    Table 111. Taisei Kako (JP) Recent Development
    Table 112. Roselabs Group (IN) Company Information
    Table 113. Roselabs Group (IN) Introduction and Business Overview
    Table 114. Roselabs Group (IN) Vial and Prefilled Syringe Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 115. Roselabs Group (IN) Vial and Prefilled Syringe Product Offerings
    Table 116. Roselabs Group (IN) Recent Development
    Table 117. ARTE CORPORATION (JP) Company Information
    Table 118. ARTE CORPORATION (JP) Introduction and Business Overview
    Table 119. ARTE CORPORATION (JP) Vial and Prefilled Syringe Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 120. ARTE CORPORATION (JP) Vial and Prefilled Syringe Product Offerings
    Table 121. ARTE CORPORATION (JP) Recent Development
    Table 122. Weigao Group Medical Polymer (CN) Company Information
    Table 123. Weigao Group Medical Polymer (CN) Introduction and Business Overview
    Table 124. Weigao Group Medical Polymer (CN) Vial and Prefilled Syringe Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 125. Weigao Group Medical Polymer (CN) Vial and Prefilled Syringe Product Offerings
    Table 126. Weigao Group Medical Polymer (CN) Recent Development
    Table 127. Zibo Minkang Pharmaceutical (CN) Company Information
    Table 128. Zibo Minkang Pharmaceutical (CN) Introduction and Business Overview
    Table 129. Zibo Minkang Pharmaceutical (CN) Vial and Prefilled Syringe Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 130. Zibo Minkang Pharmaceutical (CN) Vial and Prefilled Syringe Product Offerings
    Table 131. Zibo Minkang Pharmaceutical (CN) Recent Development
    Table 132. Shandong Pharmaceutical Glass (CN) Company Information
    Table 133. Shandong Pharmaceutical Glass (CN) Introduction and Business Overview
    Table 134. Shandong Pharmaceutical Glass (CN) Vial and Prefilled Syringe Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 135. Shandong Pharmaceutical Glass (CN) Vial and Prefilled Syringe Product Offerings
    Table 136. Shandong Pharmaceutical Glass (CN) Recent Development
    Table 137. Key Raw Materials Lists
    Table 138. Raw Materials Key Suppliers Lists
    Table 139. Vial and Prefilled Syringe Downstream Customers
    Table 140. Vial and Prefilled Syringe Distributors List
    Table 141. Research Programs/Design for This Report
    Table 142. Key Data Information from Secondary Sources
    Table 143. Key Data Information from Primary Sources
List of Figures
    Figure 1. Vial and Prefilled Syringe Product Picture
    Figure 2. Global Vial and Prefilled Syringe Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Vial and Prefilled Syringe Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Vial and Prefilled Syringe Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Vial and Prefilled Syringe Sales Price (2019-2030) & (USD/Unit)
    Figure 6. Vial and Prefilled Syringe Report Years Considered
    Figure 7. Global Vial and Prefilled Syringe Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Vial and Prefilled Syringe Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Vial and Prefilled Syringe Revenue in 2023
    Figure 10. Vial and Prefilled Syringe Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Glass Vial and Prefilled Syringe Picture
    Figure 12. Polymer Vial and Prefilled Syringe Picture
    Figure 13. Global Vial and Prefilled Syringe Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Vial and Prefilled Syringe Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Global Vial and Prefilled Syringe Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 16. Global Vial and Prefilled Syringe Sales Volume Market Share by Type, 2023 & 2030
    Figure 17. Global Vial and Prefilled Syringe Price by Type (2019-2030) & (USD/Unit)
    Figure 18. Product Picture of Antithrombotics
    Figure 19. Product Picture of Vaccines
    Figure 20. Product Picture of Autoimmune Diseases
    Figure 21. Product Picture of Anti-inflammatory Drugs
    Figure 22. Product Picture of Others
    Figure 23. Global Vial and Prefilled Syringe Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 24. Global Vial and Prefilled Syringe Sales Value Market Share by Application, 2023 & 2030
    Figure 25. Global Vial and Prefilled Syringe Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 26. Global Vial and Prefilled Syringe Sales Volume Market Share by Application, 2023 & 2030
    Figure 27. Global Vial and Prefilled Syringe Price by Application (2019-2030) & (USD/Unit)
    Figure 28. North America Vial and Prefilled Syringe Sales Value (2019-2030) & (US$ Million)
    Figure 29. North America Vial and Prefilled Syringe Sales Value by Country (%), 2023 VS 2030
    Figure 30. Europe Vial and Prefilled Syringe Sales Value (2019-2030) & (US$ Million)
    Figure 31. Europe Vial and Prefilled Syringe Sales Value by Country (%), 2023 VS 2030
    Figure 32. Asia Pacific Vial and Prefilled Syringe Sales Value (2019-2030) & (US$ Million)
    Figure 33. Asia Pacific Vial and Prefilled Syringe Sales Value by Country (%), 2023 VS 2030
    Figure 34. South America Vial and Prefilled Syringe Sales Value (2019-2030) & (US$ Million)
    Figure 35. South America Vial and Prefilled Syringe Sales Value by Country (%), 2023 VS 2030
    Figure 36. Middle East & Africa Vial and Prefilled Syringe Sales Value (2019-2030) & (US$ Million)
    Figure 37. Middle East & Africa Vial and Prefilled Syringe Sales Value by Country (%), 2023 VS 2030
    Figure 38. Key Countries/Regions Vial and Prefilled Syringe Sales Value (%), (2019-2030)
    Figure 39. Key Countries/Regions Vial and Prefilled Syringe Sales Volume (%), (2019-2030)
    Figure 40. United States Vial and Prefilled Syringe Sales Value, (2019-2030) & (US$ Million)
    Figure 41. United States Vial and Prefilled Syringe Sales Value by Type (%), 2023 VS 2030
    Figure 42. United States Vial and Prefilled Syringe Sales Value by Application (%), 2023 VS 2030
    Figure 43. Europe Vial and Prefilled Syringe Sales Value, (2019-2030) & (US$ Million)
    Figure 44. Europe Vial and Prefilled Syringe Sales Value by Type (%), 2023 VS 2030
    Figure 45. Europe Vial and Prefilled Syringe Sales Value by Application (%), 2023 VS 2030
    Figure 46. China Vial and Prefilled Syringe Sales Value, (2019-2030) & (US$ Million)
    Figure 47. China Vial and Prefilled Syringe Sales Value by Type (%), 2023 VS 2030
    Figure 48. China Vial and Prefilled Syringe Sales Value by Application (%), 2023 VS 2030
    Figure 49. Japan Vial and Prefilled Syringe Sales Value, (2019-2030) & (US$ Million)
    Figure 50. Japan Vial and Prefilled Syringe Sales Value by Type (%), 2023 VS 2030
    Figure 51. Japan Vial and Prefilled Syringe Sales Value by Application (%), 2023 VS 2030
    Figure 52. South Korea Vial and Prefilled Syringe Sales Value, (2019-2030) & (US$ Million)
    Figure 53. South Korea Vial and Prefilled Syringe Sales Value by Type (%), 2023 VS 2030
    Figure 54. South Korea Vial and Prefilled Syringe Sales Value by Application (%), 2023 VS 2030
    Figure 55. Southeast Asia Vial and Prefilled Syringe Sales Value, (2019-2030) & (US$ Million)
    Figure 56. Southeast Asia Vial and Prefilled Syringe Sales Value by Type (%), 2023 VS 2030
    Figure 57. Southeast Asia Vial and Prefilled Syringe Sales Value by Application (%), 2023 VS 2030
    Figure 58. India Vial and Prefilled Syringe Sales Value, (2019-2030) & (US$ Million)
    Figure 59. India Vial and Prefilled Syringe Sales Value by Type (%), 2023 VS 2030
    Figure 60. India Vial and Prefilled Syringe Sales Value by Application (%), 2023 VS 2030
    Figure 61. Vial and Prefilled Syringe Industrial Chain
    Figure 62. Vial and Prefilled Syringe Manufacturing Cost Structure
    Figure 63. Channels of Distribution (Direct Sales, and Distribution)
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed

Description

The global market for Vial and Prefilled Syringe was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

North American market for Vial and Prefilled Syringe was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Vial and Prefilled Syringe was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Vial and Prefilled Syringe was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Vial and Prefilled Syringe include BD (US), Gerresheimer (DE), Nipro Corporation (JP), Schott forma vitrum (DE), Ompi (IT), Baxter BioPharma Solution (US), ROVI CM (ES), Terumo (JP) and Vetter (DE), etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Vial and Prefilled Syringe, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Vial and Prefilled Syringe by region & country, by Type, and by Application.

The Vial and Prefilled Syringe market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vial and Prefilled Syringe.

Market Segmentation